Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06135324 · ClinicalTrials.gov registry record
Impairments That Affect Correct Inhaler Use in COPD
A clinical trial of COPD, sponsored by COPD Foundation.
- Active
- Registry status
- 500
- Enrollment target
- 9
- Study locations
NCT06135324: Active study of COPD, sponsored by COPD Foundation.
NCT06135324 is a study of COPD that is active but no longer recruiting, run by COPD Foundation. The registered enrollment target is 500 participants, below the 2,412-participant average among 85 other COPD trials with a reported enrollment target (79% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06135324, a study of COPD, is active but no longer recruiting, sponsored by COPD Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 9
- Study locations
Study Summary
INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.
Primary Outcome
Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with COPD.
Conditions Studied
Study Locations (9)
Alabama
- University of Alabama at Birmingham - Lung Health Center - Birmingham
Illinois
- RUSH University - Chicago
Massachusetts
- Lahey Clinic, Inc. - Burlington
Missouri
- Midwest Chest Consultants, PC - Saint Charles
New Hampshire
- Valley Regional Hospital - Claremont
North Carolina
- Atrium Health Wake Forest Baptist - Winston-Salem
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Tennessee
- Erlanger Health - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-14 |
| Est. Completion | 2025-10-31 |
What the registry record for NCT06135324 still lists
NCT06135324 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 2,412-participant average among 85 other COPD trials with a reported enrollment target (79% lower).
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 0 interventions.
NCT06135324 lists 9 locations in 9 states (Alabama, Illinois, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06135324 about?
NCT06135324 is a clinical study titled "Impairments That Affect Correct Inhaler Use in COPD". INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive im...
What is the current status of trial NCT06135324?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2023-12-14. Estimated completion is 2025-10-31.
What conditions does trial NCT06135324 study?
This clinical trial studies the following conditions: COPD.
Who is sponsoring clinical trial NCT06135324?
This trial is sponsored by COPD Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06135324 being conducted?
This trial has 9 study locations across Alabama, Illinois, Massachusetts, Missouri, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06135324's enrollment target sits among peer trials
500 16th of 85 higher than 70 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI